Neuromyelitis Optica
Showing 1 - 25 of 160
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica
- Efgartigimod
- Intravenous methylprednisolone (IVMP) and Efgartigimod
- IVMP
- (no location specified)
Nov 1, 2023
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorders
- (no location specified)
Sep 29, 2023
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Neuromyelitis Optica Spectrum Disorder Relapse Trial in Tianjin (Ruxolitinib)
Withdrawn
- Neuromyelitis Optica Spectrum Disorder Relapse
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Jun 10, 2023
Neuromyelitis Optica Spectrum Disorder Exposed to UPLIZNA®
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Pregnancy Related
- (no location specified)
Jun 9, 2023
Neuromyelitis Optica Trial in Hangzhou (CD19 CAR-T cells injection)
Recruiting
- Neuromyelitis Optica
- CD19 CAR-T cells injection
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 12, 2023
NMO Spectrum Disorder Trial in Tianjin (Baricitinib)
Not yet recruiting
- NMO Spectrum Disorder
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Mar 18, 2023
NMO Spectrum Disorder, Azathioprine Adverse Reaction Trial in Nanning (Azathioprine)
Completed
- NMO Spectrum Disorder
- Azathioprine Adverse Reaction
-
Nanning, Guangxi, ChinaQingmeng Huang
Jun 8, 2023
NMO Spectrum Disorder, Spasticity, Muscle Trial in Boston (Nabiximols, Placebo)
Not yet recruiting
- NMO Spectrum Disorder
- Spasticity, Muscle
- Nabiximols
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Aug 2, 2023
Restless Legs Syndrome in People With Neuromyelitis Optica
Recruiting
- Neuromyelitis Optica
- Restless Legs Syndrome
- assessments
-
İzmir, TurkeyDokuz Eylul University
Oct 6, 2022
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)
Recruiting
- Neuromyelitis Optica
- +2 more
- Daratumumab
- Placebo
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Oct 19, 2022
Neuromyelitis Optica Spectrum Disorders, Pain Trial in Guangzhou (electroacupuncture)
Completed
- Neuromyelitis Optica Spectrum Disorders
- Pain
- electroacupuncture
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
May 20, 2023
NMO Spectrum Disorder Trial (Acceptance and Commitment Therapy)
Not yet recruiting
- NMO Spectrum Disorder
- Acceptance and Commitment Therapy
- (no location specified)
Apr 21, 2023
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
Neuromyelitis Optica Trial in Boston (NMOSDCopilot smartphone application)
Not yet recruiting
- Neuromyelitis Optica
- NMOSDCopilot smartphone application
-
Boston, MassachusettsMassachussets General Hospital
Dec 21, 2022
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- +2 more
- (no location specified)
Jul 21, 2023
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (MIL62, Placebo)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- MIL62
- Placebo
- (no location specified)
May 26, 2022
Neuromyelitis Optica Spectrum Disorder, NMOSD Trial in Le Kremlin-bicêtre, Gdansk (Satralizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
- NMOSD
-
Le Kremlin-bicêtre, France
- +1 more
Aug 17, 2022
Longitudinal Cortical Demyelination in Multiple Sclerosis and
Recruiting
- Multiple Sclerosis
- +2 more
-
New York, New YorkMount Sinai Hospital
Aug 8, 2023
Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Barcelona, SpainClinical Trial Site
Jul 6, 2022
Neuropsychology and Imaging in CNS Demyelinating Syndromes.
Active, not recruiting
- Multiple Sclerosis, Relapsing-Remitting
- +3 more
-
Dallas, TexasUniversity Texas Southwestern
Dec 14, 2022
Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica Spectrum Related Disorders Trial in Bron
Completed
- Neuromyelitis Optica Spectrum Disorders
- Neuromyelitis Optica Spectrum Related Disorders
-
Bron, FranceHospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer
Mar 29, 2022
Egyptian Patients With Neuromyelitis Optica Spectrum Disorder
Not yet recruiting
- Assessment of Serum FAM19A5level in Egyptian Patients With NMOSD
- serum level of FAM19A5
- (no location specified)
Jul 4, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Xi'an (Ofatumumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Xi'an, Shaanxi, ChinaTangdu Hospital
Aug 16, 2022
Neuromyelitis Optica, NMO Spectrum Disorder Trial in Rochester
Recruiting
- Neuromyelitis Optica
- NMO Spectrum Disorder
-
Rochester, MinnesotaMayo Clinic
Mar 11, 2022